Please check your internet connection and try again.
# Miconazole Vaginal Pessary
## Overview
Miconazole is an imidazole antifungal agent. The vaginal pessary formulation is used for the topical treatment of vulvovaginal candidiasis (yeast infections).
## Primary Indications
Treatment of vulvovaginal candidiasis (yeast infections).
## Adult Dosing
* **Option 1 (Single Dose):** Insert one 1200 mg vaginal pessary into the vagina once at bedtime.
* **Option 2 (Three-Day Regimen):** Insert one 200 mg vaginal pessary into the vagina at bedtime for 3 consecutive nights.
* **Option 3 (Seven-Day Regimen):** Insert one 100 mg vaginal pessary into the vagina at bedtime for 7 consecutive nights.
The choice of regimen may depend on clinical judgment and patient factors. Complete the full course of treatment even if symptoms improve earlier.
## Pediatric Dosing
Data on the use of miconazole vaginal pessaries in pediatric patients is limited. Consult current pediatric guidelines and product information for appropriate dosing and use in this population. Age restrictions may apply.
## Dose Adjustments
No dose adjustments are typically required for renal or hepatic impairment due to minimal systemic absorption.
## Contraindications
* Hypersensitivity to miconazole or any component of the formulation.
* Use with CYP3A4 inhibitors (e.g., warfarin, certain protease inhibitors, macrolides) is contraindicated due to the risk of increased systemic drug concentrations and potential toxicity, though systemic absorption from vaginal pessaries is minimal. However, caution is advised.
## Adverse Effects
* **Common:** Vaginal burning, itching, irritation, pelvic pain, cramping.
* **Less Common:** Headache, vulvar/vaginal dryness, rash.
## Key Drug Interactions
Systemic absorption is generally low, but significant drug interactions are possible if absorbed systemically. Miconazole is a potent inhibitor of CYP3A4. Concomitant use with CYP3A4 substrates (e.g., warfarin, simvastatin, atorvastatin, certain immunosuppressants like cyclosporine and tacrolimus) may lead to increased plasma concentrations of these drugs, potentially causing serious adverse events. Patients should be advised to avoid concomitant use or use with extreme caution and monitoring.
## Monitoring
* Monitor for signs of local irritation or allergic reaction.
* If using concurrently with interacting medications (e.g., warfarin), monitor for signs of toxicity of the interacting drug.
## Clinical Pearls
* Pessaries should be inserted deep into the vagina, preferably at bedtime to minimize leakage.
* Treatment should be completed even if symptoms resolve before the end of the prescribed course.
* Avoid intercourse during treatment.
* If symptoms persist after completing treatment, or if symptoms worsen, re-evaluate the diagnosis and consider alternative therapy.
* The 1200 mg single-dose pessary offers convenience but may have a higher incidence of local irritation compared to multi-day regimens for some individuals.
***
*Please verify this information with the most current prescribing information and relevant clinical guidelines before use.*